These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8452657)

  • 21. Malaria pharmacovigilance in Africa: lessons from a pilot project in Mpumalanga Province, South Africa.
    Mehta U; Durrheim D; Mabuza A; Blumberg L; Allen E; Barnes KI
    Drug Saf; 2007; 30(10):899-910. PubMed ID: 17867727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unusual pulmonary reaction during short term prophylaxis with pyrimethamine-sulfadoxine (Fansidar).
    Svanbom M; Rombo L; Gustafsson L
    Br Med J (Clin Res Ed); 1984 Jun; 288(6434):1876. PubMed ID: 6428585
    [No Abstract]   [Full Text] [Related]  

  • 23. Serious reactions during malaria prophylaxis with pyrimethamine-sulfadoxine.
    Olsen VV; Loft S; Christensen KD
    Lancet; 1982 Oct; 2(8305):994. PubMed ID: 6127497
    [No Abstract]   [Full Text] [Related]  

  • 24. Fansimef for prophylaxis of malaria: a double-blind randomized placebo controlled trial.
    Bunnag D; Malikul S; Chittamas S; Chindanond D; Harinasuta T; Fernex M; Mittelholzer ML; Kristiansen S; Sturchler D
    Southeast Asian J Trop Med Public Health; 1992 Dec; 23(4):777-82. PubMed ID: 1298089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment failure of falciparum malaria with Fansidar in Tawau Sabah. January-June, 1982.
    Tan Heng Soon ; Tan Puay Eng
    Med J Malaysia; 1983 Sep; 38(3):217-23. PubMed ID: 6369092
    [No Abstract]   [Full Text] [Related]  

  • 26. Serious adverse drug reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain.
    Phillips-Howard PA; West LJ
    J R Soc Med; 1990 Feb; 83(2):82-5. PubMed ID: 2138674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tolerability of long-term prophylaxis with fansidar: a randomized double-blind study in Nigeria.
    Stemberger H; Leimer R; Wiedermann G
    Acta Trop; 1984 Dec; 41(4):391-9. PubMed ID: 6152120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leads from the MMWR. Fansidar-associated fatal reaction in an HIV-infected man.
    JAMA; 1988 Oct; 260(15):2193. PubMed ID: 3262778
    [No Abstract]   [Full Text] [Related]  

  • 29. [Acute hepatitis following administration of fansidar].
    Meier P; Schmid M; Stäubli M
    Schweiz Med Wochenschr; 1990 Feb; 120(7):221-5. PubMed ID: 2309111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Eosinophilic lung infiltration during malaria prophylaxis with pyrimethamine-sulfadoxine (Fansidar)].
    Buser P; Räber J
    Schweiz Med Wochenschr; 1985 Aug; 115(34):1174-6. PubMed ID: 4048913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of mefloquine, chloroquine plus pyrimethamine-sulfadoxine (Fansidar), and chloroquine as malarial prophylaxis in eastern Thailand.
    Boudreau EF; Pang LW; Chaikummao S; Witayarut C
    Southeast Asian J Trop Med Public Health; 1991 Jun; 22(2):183-9. PubMed ID: 1948277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe cutaneous adverse reactions to sulfadoxine-pyrimethamine in Switzerland.
    Steffen R; Somaini B
    Lancet; 1986 Mar; 1(8481):610. PubMed ID: 2869315
    [No Abstract]   [Full Text] [Related]  

  • 33. [Drug-induced exudative erythema multiforme major with a chronic progressive course and bilateral blindness. Clinical and immunohistologic follow-up].
    Thiel HJ; Richter U; Pleyer U; Zierhut M; Steuhl KP
    Klin Monbl Augenheilkd; 1990 Aug; 197(2):142-9. PubMed ID: 2147046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stevens-Johnson syndrome in two children in Ghana following anti-malarial treatment.
    Oduro-Boatey C; Rodrigues O
    Trop Doct; 2005 Apr; 35(2):118-9. PubMed ID: 15970046
    [No Abstract]   [Full Text] [Related]  

  • 35. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients.
    Chan HL; Stern RS; Arndt KA; Langlois J; Jick SS; Jick H; Walker AM
    Arch Dermatol; 1990 Jan; 126(1):43-7. PubMed ID: 2404462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulfadoxine specific lymphocyte transformation in a patient with eosinophilic pneumonia induced by sulfadoxine-pyrimethamine (Fansidar).
    Daniel PT; Holzschuh J; Berg PA
    Thorax; 1989 Apr; 44(4):307-9. PubMed ID: 2763233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three cases of acquired immunodeficiency syndrome complicated with toxic epidermal necrolysis.
    Kimura S; Oka S; Mohri H; Mitamura K; Shimada K
    Jpn J Med; 1991; 30(6):553-8. PubMed ID: 1798215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of Congenital Toxoplasmosis: Safety of the Sulfadoxine-Pyrimethamine Combination in Children Based on a Method of Causality Assessment.
    Teil J; Dupont D; Charpiat B; Corvaisier S; Vial T; Leboucher G; Wallon M; Peyron F
    Pediatr Infect Dis J; 2016 Jun; 35(6):634-8. PubMed ID: 26906163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse reactions to Fansidar and updated recommendations for its use in the prevention of malaria.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Jan; 33(51-52):713-4. PubMed ID: 3917533
    [No Abstract]   [Full Text] [Related]  

  • 40. Fatal multisystemic toxicity associated with prophylaxis with pyrimethamine and sulfadoxine (Fansidar).
    Selby CD; Ladusans EJ; Smith PG
    Br Med J (Clin Res Ed); 1985 Jan; 290(6462):113-4. PubMed ID: 3155635
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.